Ultragenyx Pharmaceutical Inc. RARE NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

56/100

3/7 Pass

SharesGrow Intrinsic Value

Ha habido 50 transacciones internas recientes registradas para Ultragenyx Pharmaceutical Inc. (RARE), incluyendo 18 compras y 32 ventas. El total de compras internas fue valorado en $7.36M y el total de ventas internas en $8.65M.

Internos destacados con actividad reciente incluyen Horn Howard, Parschauer Karah Herdman, Kakkis Emil D. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — RARE

Fecha	Nombre	Cargo	Tipo de Transacción	Acciones	Precio Promedio	Valor	Acciones en Propiedad
2026-04-01	Horn Howard	Chief Financial Officer	Venta Informativa	4,683	$20.97	$98.2K	80,351
2026-03-10	Parschauer Karah Herdman	EVP and Chief Legal Officer	Venta Informativa	3,508	$22.67	$79.53K	66,820
2026-03-06	Parschauer Karah Herdman	EVP and Chief Legal Officer	Venta Informativa	6,018	$21.40	$128.79K	70,328
2026-03-03	Horn Howard	Chief Financial Officer	Venta Informativa	1,635	$22.40	$36.62K	85,034
2026-03-02	Kakkis Emil D	President & CEO	Venta Informativa	54,404	$22.80	$1.24M	658,994
2026-03-02	Huizenga Theodore Alan	SVP, Chief Accounting Officer	Venta Informativa	1,632	$22.80	$37.21K	48,670
2026-03-02	Huang Dennis Karl	See Remarks	Retención Fiscal de RSU	999	$23.39	$23.37K	124,729
2026-03-02	Pinion John Richard	See Remarks	Venta Informativa	10,029	$22.80	$228.66K	110,026
2026-03-02	Crombez Eric	EVP and Chief Medical Officer	Venta Informativa	7,029	$22.80	$160.26K	76,301
2026-03-02	Parschauer Karah Herdman	EVP and Chief Legal Officer	Venta Informativa	8,135	$22.80	$185.48K	76,346
2026-03-02	Harris Erik	EVP & Chief Commercial Officer	Venta Informativa	10,539	$22.80	$240.29K	89,515
2026-03-02	Horn Howard	Chief Financial Officer	Venta Informativa	3,119	$22.54	$70.3K	86,669
2026-03-01	Kakkis Emil D	President & CEO	Concesión de RSU	71,177	-	-	712,908
2026-03-01	Huang Dennis Karl	See Remarks	Concesión de RSU	11,137	-	-	125,728
2026-03-01	Pinion John Richard	See Remarks	Concesión de RSU	11,137	-	-	119,565
2026-03-01	Crombez Eric	EVP and Chief Medical Officer	Concesión de RSU	11,643	-	-	83,173
2026-03-01	Parschauer Karah Herdman	EVP and Chief Legal Officer	Concesión de RSU	11,137	-	-	84,408
2026-03-01	Harris Erik	EVP & Chief Commercial Officer	Concesión de RSU	11,643	-	-	99,498
2026-03-01	Horn Howard	Chief Financial Officer	Concesión de RSU	6,143	-	-	95,078
2026-02-02	Horn Howard	Chief Financial Officer	Venta Informativa	3,061	$23.56	$72.12K	88,935
2026-01-02	Horn Howard	Chief Financial Officer	Venta Informativa	3,150	$22.84	$71.95K	91,996
2025-12-29	Huizenga Theodore Alan	SVP, Chief Accounting Officer	Venta Informativa	85	$34.38	$2.92K	50,450
2025-12-10	Horn Howard	Chief Financial Officer	Venta Informativa	3,081	$36.38	$112.09K	95,146
2025-10-13	Horn Howard	Chief Financial Officer	Venta Informativa	7,942	$31.51	$250.25K	98,227
2025-09-18	Huizenga Theodore Alan	SVP, Chief Accounting Officer	Venta Informativa	64	$29.17	$1.87K	50,242
2025-09-12	Parschauer Karah Herdman	EVP and Chief Legal Officer	Venta Informativa	2,450	$31.17	$76.37K	73,271
2025-09-05	Huizenga Theodore Alan	SVP, Chief Accounting Officer	Venta Informativa	84	$31.39	$2.64K	50,306
2025-06-20	Sanders Corazon (corsee) D.	Director	Venta Informativa	2,405	$37.39	$89.92K	15,344
2025-05-15	Welch Daniel G	Director	Concesión de RSU	10,787	$34.84	$375.82K	10,787
2025-05-15	Dunsire Deborah	Director	Concesión de RSU	10,787	$34.84	$375.82K	10,787
2025-05-15	Narachi Michael	Director	Concesión de RSU	10,787	$34.84	$375.82K	10,787
2025-05-15	Fust Matthew K	Director	Concesión de RSU	10,787	$34.84	$375.82K	10,787
2025-05-15	Suliman Shehnaaz	Director	Concesión de RSU	10,787	$34.84	$375.82K	10,787
2025-05-15	Sanders Corazon (corsee) D.	Director	Concesión de RSU	10,787	$34.84	$375.82K	10,787
2025-05-15	Ray Amrit	Director	Concesión de RSU	10,787	$34.84	$375.82K	10,787
2025-05-05	Crombez Eric	EVP and Chief Medical Officer	Venta Informativa	520	$39.24	$20.4K	71,530
2025-04-21	Crombez Eric	EVP and Chief Medical Officer	Venta Informativa	242	$35.11	$8.5K	71,680
2025-03-06	Horn Howard	Chief Financial Officer	Venta Informativa	1,785	$40.40	$72.11K	106,169
2025-03-03	Kakkis Emil D	President & CEO	Venta Informativa	73,434	$42.10	$3.09M	641,731
2025-03-03	Kassberg Thomas Richard	Cbo & EVP	Retención Fiscal de RSU	508	$42.92	$21.8K	264,730
2025-03-03	Huizenga Theodore Alan	SVP, Chief Accounting Officer	Retención Fiscal de RSU	141	$42.92	$6.05K	50,124
2025-03-03	Huang Dennis Karl	See Remarks	Retención Fiscal de RSU	1,348	$42.92	$57.86K	114,591
2025-03-03	Pinion John Richard	See Remarks	Venta Informativa	14,439	$42.10	$607.88K	107,766
2025-03-03	Crombez Eric	EVP and Chief Medical Officer	Venta Informativa	8,945	$42.10	$376.58K	71,922
2025-03-03	Parschauer Karah Herdman	EVP and Chief Legal Officer	Venta Informativa	12,846	$42.10	$540.82K	75,287
2025-03-03	Harris Erik	EVP & Chief Commercial Officer	Venta Informativa	15,103	$42.10	$635.84K	87,855
2025-03-01	Parschauer Karah Herdman	EVP and Chief Legal Officer	Concesión de RSU	26,074	$42.92	$1.12M	26,074
2025-03-01	Kakkis Emil D	President & CEO	Concesión de RSU	78,448	$42.92	$3.37M	78,448
2025-03-01	Kassberg Thomas Richard	Cbo & EVP	Concesión de RSU	18,443	-	-	271,266
2025-03-01	Huizenga Theodore Alan	SVP, Chief Accounting Officer	Concesión de RSU	5,632	$42.92	$241.73K	5,632

■ Informativa — transacción en mercado abierto (más significativa) ■ No informativa (compra) — premio, ejercicio de opción, conversión ■ No informativa (venta) — retención fiscal, venta de adjudicación ■ Neutral — regalo, fideicomiso, vencimiento